S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    -0.00 (-0.13%)

    Market Cap: $11.74M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(6/13)
    Avg Surprise
    -7.39%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.29
    Range$-0.38 - $-0.21
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.32-9.6%
    60d ago$-0.38-27.7%
    30d ago$-0.38-27.7%
    7d ago$-0.38-27.7%
    Current$-0.29
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.13
    Range$-0.39 - $0.14
    2 analysts
    Revenue Consensus
    $50000
    Range$0 - $100000
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.13---
    Sep 26EST
    		-$-0.29---
    Jun 26
    		$-0.41$-0.33-24.24%Miss+26.8%
    Mar 26
    		$-0.14N/A+61.11%Beat+90.1%
    Dec 25
    		$-0.53$-0.47-11.98%Miss+20.9%
    Sep 25
    		$-0.69$-0.57-21.05%Miss+89.1%
    Jun 25
    		$-0.56$-0.55-1.82%Miss+77.1%
    Mar 25
    		$-1.41$-0.56-151.79%Miss-432.1%
    Dec 24
    		$-0.67N/A+78.59%Beat-59.9%
    Sep 24
    		$-6.31N/AN/ABeat-156.4%
    Jun 24
    		$-2.45N/AN/ABeat+41.7%
    Mar 24
    		$-0.27$0.00N/ABeat+93.7%
    Dec 23
    		$-0.42$-0.23-82.22%Miss+0.2%
    Sep 23
    		$-2.46$-4.28+42.52%Beat+35.3%
    Jun 23
    		$-4.20$-4.64+9.48%Beat-643.4%
    Mar 23
    		$-4.20$-3.90-7.69%Miss-10400.0%
    Dec 22
    		$-0.42$-0.44+4.55%Beat-281.8%
    Sep 22
    		$-3.80$-4.15+8.43%Beat-37900.0%
    Jun 22
    		$-0.56N/AN/ABeat-5550.0%
    Mar 22
    		$-0.04N/AN/ABeat-
    Dec 21
    		$-0.11N/AN/ABeat-
    Sep 21
    		$-0.01N/AN/ABeat-
    Jun 21
    		$-0.01N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.21EV/EBITDA-0.28x
    Price/FCF-0.31xFCF Yield-324.07%
    Profitability
    Profit Margin0.00%Operating Margin-79371.00%
    ROE-466.50%ROIC-6697.39%
    Financial Health
    Debt/Equity-1.17xInterest CoverageN/A
    Current Ratio0.83xQuick Ratio0.83x
    Trading Statistics
    Beta2.11Avg Volume223.04K
    52-Week High$2.5552-Week Low$0.33

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.41
    SMA 20$0.39
    SMA 50$0.62
    SMA 200$1.00
    EMA 10$0.39
    EMA 20$0.42
    EMA 50$0.56
    EMA 200$1.04

    MACD

    Line: -0.05Signal: -0.06Hist: 0.01

    ADX

    ADX: 32.6+DI: 15.1-DI: 27.1

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down84.0
    PSAR$0.45

    Bollinger Bands

    Upper Band$0.46
    Lower Band$0.32
    %B Position3373%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    37.3

    Momentum Oscillators

    Stoch %K33.9
    Stoch %D36.0
    Williams %R-68.4
    ROC (10d)-16.0%
    Momentum-0.07
    CCI (20d)-28.2
    MFI (14d)45.0

    Volatility Measures

    ATR (14d)$0.05(12.9%)
    StdDev (20d)0.03
    Hist Vol95.5%(High)

    Volume Flow

    VWAP$0.38
    OBV-97.9M
    AD Line-80.4M
    CMF (20d)0.130

    Volume Metrics

    Avg Vol (20d)230.8K
    Vol Ratio0.4x(Low)
    VWMA (20d)$0.40

    Pivot Points

    R3$0.44
    R2$0.42
    R1$0.40
    Pivot Point$0.38
    S1$0.35
    S2$0.33
    S3$0.31

    Advanced Oscillators

    TSI-26.57
    Ultimate Osc49.7
    KST-173.89

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17,000$16,000$22,000$0$0$0$5.86M$0$0$0$333,000$338,000
    Cost of Revenue$0$0$893,000$0$0$0$1.46M$0$0$0$1.47M$0
    Gross Profit$17,000$16,000$22,000$0$0$0$-1,459,000$0$0$0$-1,141,000$338,000
    Operating Expenses$14.51M$4.63M$18.66M$16.95M$16.80M$16.40M$16.17M$15.21M$13.36M$16.30M$18.70M$44.21M
    R&D$7.77M$5.28M$7.76M$10.52M$10.03M$9.28M$7.77M$8.65M$9.15M$8.78M$9.12M$9.09M
    SG&A$6.74M$6.23M$5.85M$6.43M$6.77M$7.12M$8.08M$6.56M$4.21M$7.52M$9.30M$9.43M
    Operating Income$-14,489,000$-4,616,000$-18,636,000$-16,948,000$-16,798,000$-16,397,000$-16,167,000$-15,215,000$-13,356,000$-16,301,000$-18,699,000$-43,876,000
    Interest Income$55,000$101,000$97,000$166,000$270,000$394,000$231,000$150,000$236,000$331,000$426,000$583,000
    Interest Expense$0$0$0$1.18M$0$0$0$13.65M$0$0$0$0
    Income Before Tax$-12,750,000$-4,235,000$-14,658,000$-18,126,000$-14,733,000$-13,912,000$-563,000$-28,866,000$-11,203,000$-12,111,000$-18,689,000$-36,615,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-12,750,000$-4,221,000$-14,467,000$-18,126,000$-14,733,000$-14,112,000$-610,000$-28,866,000$-11,203,000$-12,111,000$-18,716,000$-14,923,000
    EBITDA$-12,138,000$-3,648,000$-13,862,000$-17,388,000$-14,089,000$-13,380,000$143,000$-28,070,000$-10,468,000$-11,458,000$-17,641,000$-35,500,000
    EBIT$-12,805,000$-4,336,000$-14,755,000$-18,292,000$-15,003,000$-14,306,000$-794,000$-29,016,000$-11,439,000$-12,442,000$-19,115,000$-37,198,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SNTI

    News

    Senti Biosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

    Senti Biosciences Holdings, Inc. reported its earnings results for the second quarter and six months ended June 30, 2026. For the second quarter, the company's net loss decreased to USD 12.75 million from USD 14.73 million a year prior, with basic and diluted loss per share at USD 0.41. For the six-month period, the net loss significantly narrowed to USD 16.97 million compared to USD 28.85 million in the previous year, resulting in a basic and diluted loss per share of USD 0.55.

    www.marketscreener.com•8/14/26•
    Bullish

    Senti Biosciences Inc (SNTI) Financial Health: Profitability & Balance Sheet Analysis

    Senti Biosciences Inc (SNTI) has a weak financial status with a current financial score of 5.90, ranking 315 out of 385 in the Biotechnology & Medical Research industry. The company's operating efficiency is low, and relevant financial data for various metrics like quality of earnings, operational efficiency, growth potential, and shareholder returns have not been disclosed by the company.

    TradingKey•7/30/26•
    Somewhat-Bearish

    Senti Biosciences Inc (SNTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

    This article from TradingKey reports on Senti Biosciences Inc (SNTI) and its revenue breakdown. It states that relevant data regarding the company's business segments, regional revenue, and profit contribution have not yet been disclosed by Senti Biosciences Inc. The article provides current market data for SNTI, including its stock price and market capitalization.

    TradingKey•7/27/26•
    Somewhat-Bearish

    Senti Biosciences Inc (SNTI) Cash Flow

    This article provides a detailed cash flow statement for Senti Biosciences Inc (SNTI), covering quarterly and annual figures for operating, investing, and financing activities. It also includes explanations of key cash flow terms like operating cash flow, investing cash flow, financing cash flow, and free cash flow, along with SNTI-specific figures for recent periods. The data helps evaluate the company's financial soundness and stability.

    TradingKey•7/27/26•
    Somewhat-Bearish

    SNTI|Senti Biosciences Inc|Price:0.448|

    This article provides a detailed financial summary for Senti Biosciences Inc. (SNTI), showcasing its income statement, balance sheet, and cash flow statement. It emphasizes key financial indicators, earnings per share, revenue, and net profit performance across various quarters and fiscal years. The content aims to equip investors with comprehensive data for smart investment decisions regarding Senti Biosciences.

    TradingKey•7/24/26•
    Bearish

    Frequently Asked Questions About SNTI

    Does SNTI pay dividends?
    Senti Biosciences Inc (SNTI) does not currently pay a regular dividend.
    What is SNTI's market cap?
    Senti Biosciences Inc (SNTI) has a market capitalization of $11.74M with a current stock price of $0.38.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In